Background. We conducted a population-based, nation-wide, prospective study to identify
who introduced pertussis into the household of infants aged⩽ 6 months admitted to the …

Currently, there are 2 tetanus and reduced antigen content diphtheria and acellular
pertussis vaccines (Tdap vaccines; called dTpa in Europe) available for the immunization of …

B. pertussis produces multiple antigenic and biologically active products, including pertussis
toxin (PT), filamentous hemagglutinin (FHA), agglutinogens, adenylate cyclase, pertactin …

Young children in New Zealand remain at an unacceptably high risk of pertussis. As an
indicator of child disease burden hospitalisation rates have increased in each decade since …

Background Despite widespread immunization programs, a clear increase in pertussis
incidence is apparent in many developed countries during the last decades. Consequently …

In July 2009, the German Standing Committee on Vaccination (STIKO) modified its
recommendations for varicella and pertussis vaccination, based on newly available data on …

Healthcare workers'(HCWs) knowledge, attitudes, and beliefs regarding pertussis
immunization were assessed and compared to the rate of vaccine uptake. A questionnaire …

We describe an outbreak of pertussis with transmission between health care workers
(HCWs) in a hospital oncology department and a patient identified as a possible source …

Introducción La enfermedad por Bordetella pertussis es un problema de salud pública a
nivel mundial. Se estiman de 20 a 40 millones de casos y 200.000 a 400.000 muertes con …

BACKGROUND: Between July 1997 and April 1998, Canadian public health agencies
switched from the whole cell vaccine (WCE) to the acellular vaccine (AcE) for pertussis …